Celebrating 40 Years of UHN's Liver Transplant Program: A Journey of Innovation and Hope
In 1985, a groundbreaking decision by a small team of physicians at UHN and partner hospitals marked the beginning of a remarkable journey. They dared to challenge liver failure, a diagnosis once considered a death sentence, by harnessing science, skill, determination, and a shared vision. Today, four decades later, UHN's Liver Transplant Program has become a beacon of hope, surpassing 4,800 liver transplants—the most in North America—and transforming what was once experimental into a life-saving medical procedure.
This milestone is a testament to the unwavering commitment of healthcare professionals and researchers, the generosity of donors, and the resilience of patients like Doug Munro. For patients with chronic liver disease, liver transplantation is often the only treatment option that can save their lives.
During the early days of liver transplantation, physicians faced significant challenges, including managing immunosuppression and combating post-surgery infections. UHN physicians advocated for investment in research and innovation, laying the foundation for the program's current status as Canada's largest liver transplant program. Now, as part of the Ajmera Transplant Centre, the program is recognized internationally for its leadership in patient care and education.
Dr. Markus Selzner, Surgical Director since 2018, highlights the program's innovative approach: "Throughout our history, we've implemented groundbreaking innovations. We're doing things we've never done before, and we're completing transplants in patients we wouldn't have considered 20 years ago."
Two key factors have driven this growth and innovation: UHN's ex-vivo organ perfusion technology and living donor program. Initially used in lung transplantation, ex-vivo technology, which keeps organs alive outside the body by mimicking body temperature and providing nutrients, is now being widely adopted for liver transplants under Dr. Selzner's leadership.
Despite the evolving nature of surgery and transplantation, the demand for liver transplants continues to outpace the number of procedures performed. UHN's Centre for Living Organ Donation aims to address this need by raising awareness, promoting research, and offering patients a faster pathway to kidney and liver transplants.
Dr. Elmar Jaeckel, Medical Director since 2022, emphasizes the success of the living donor program: "About 30 to 40 percent of our transplants are from living donors, and it's a huge success."
This success is attributed to the collaborative efforts of UHN's highly specialized team, who remain committed to innovative patient care. Dr. Jaeckel adds, "We're always working together to push boundaries. We're also at the forefront of using artificial intelligence for decision-making and cell and gene therapy to minimize the side effects of lifelong immunosuppression."
Doug Munro's story exemplifies the life-changing impact of UHN's Liver Transplant Program. In the fall of 2023, Doug, aged 62, experienced liver failure symptoms and was diagnosed with non-alcoholic fatty liver disease. His condition worsened, leading to ascites and other serious symptoms. Despite being on a waiting list for a donated liver, time was critical.
On a fateful day, Doug received a phone call from Toronto General Hospital, offering an immediate liver transplant. Within hours, he was back at the hospital, ready for the life-saving surgery. Doug's recovery has been challenging but successful, and he expresses his gratitude to UHN, his surgeon, and the team, as well as to his supportive wife.
Looking ahead, the Liver Transplant Program holds exciting promises in advancing robotic surgeries, improving immunosuppression treatments, and expanding access to transplantation. Dr. Selzner envisions a future where more healthy livers are available, and no one dies on the organ waiting list.
As UHN continues to innovate and push boundaries, the Liver Transplant Program remains dedicated to its mission, driven by the dedication of researchers and the commitment to patient care that has made it a global leader in liver transplantation.
